Home/Guided Therapeutics/Mark L. Faupel Ph.D.

ML

Mark L. Faupel Ph.D.

President, CEO, Board Member

Guided Therapeutics

Therapeutic Areas

Oncology Women's Health

Guided Therapeutics Pipeline

Drug	Indication	Phase
LuViva® Advanced Cervical Scan	Cervical Intraepithelial Neoplasia (CIN) / Cervical Cancer Detection	Commercial / PMA Submission
Biophotonic Platform - Esophageal Application	Esophageal Cancer Detection	Research & Development

Leadership Team at Guided Therapeutics

Michael C. James

Board Chair, Chair of Audit Committee

John E. Imhoff M.D.

Board Member, Compensation Committee Chair

View full Guided Therapeutics profile